Neovasc Inc. Income from Discontinued Operations

Income from Discontinued Operations of NVCN for past 10 years: annual, quarterly and twelve month trailing (TTM) including Income from Discontinued Operations growth rates and interactive chart.


Highlights and Quick Summary

  • Income from Discontinued Operations for the quarter ending December 31, 2015 was $0 (a NaN% decrease compared to previous quarter)
  • Year-over-year quarterly Income from Discontinued Operations decreased by NaN%
  • Annual Income from Discontinued Operations for 2013 was $0 (a NaN% decrease from previous year)
  • Annual Income from Discontinued Operations for 2012 was $0 (a NaN% decrease from previous year)
  • Twelve month Income from Discontinued Operations ending December 31, 2015 was $0 (a NaN% decrease compared to previous quarter)
  • Twelve month trailing Income from Discontinued Operations decreased by NaN% year-over-year
Trailing Income from Discontinued Operations for the last four month:
31 Dec '15 30 Sep '15 31 Dec '14 30 Sep '14
$0 $0 $0 $0
Visit stockrow.com/NVCN for comprehensive keystats, realtime prices, income statement, balance sheet, cash flow statement with 10 years of data, and state-of-the-art screener.

Historical Income from Discontinued Operations of Neovasc Inc.

Most recent Income from Discontinued Operationsof NVCN including historical data for past 10 years.

Interactive Chart of Income from Discontinued Operations of Neovasc Inc.

Neovasc Inc. Income from Discontinued Operations for the past 10 Years (both Annual and Quarterly)

(All values are in $ million)

Year Q1 Q2 Q3 Q4 Fiscal Year
2015 $0.0 $0.0
2014 $0.0 $0.0 $0.0 $0.0
2013 $0.0 $0.0 $0.0 $0.0 $0.0
2012 $0.0 $0.0 $0.0 $0.0 $0.0
2011 $0.0 $0.0

Business Profile of Neovasc Inc.

Sector: Healthcare
Industry: Medical Devices
Neovasc Inc., a specialty medical device company, develops, manufactures, and markets products for cardiovascular marketplace in Europe and internationally. Its products include the Tiara technology for the transcatheter treatment of mitral valve disease; and the Neovasc Reducer for the treatment of refractory angina. The company was formerly known as Medical Ventures Corp. and changed its name to Neovasc Inc. in July 2008. Neovasc Inc. was incorporated in 2000 and is headquartered in Richmond, Canada.